12,469 Shares in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Acquired by EP Wealth Advisors LLC

EP Wealth Advisors LLC bought a new position in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 12,469 shares of the real estate investment trust’s stock, valued at approximately $232,000.

A number of other institutional investors have also recently bought and sold shares of the stock. Envestnet Asset Management Inc. boosted its position in shares of Sabra Health Care REIT by 7.1% during the second quarter. Envestnet Asset Management Inc. now owns 579,110 shares of the real estate investment trust’s stock worth $8,918,000 after buying an additional 38,144 shares during the period. Renaissance Technologies LLC boosted its position in Sabra Health Care REIT by 77.0% during the 2nd quarter. Renaissance Technologies LLC now owns 1,287,279 shares of the real estate investment trust’s stock worth $19,824,000 after acquiring an additional 559,800 shares during the last quarter. Texas Permanent School Fund Corp grew its stake in shares of Sabra Health Care REIT by 22.1% during the 2nd quarter. Texas Permanent School Fund Corp now owns 247,000 shares of the real estate investment trust’s stock worth $3,804,000 after acquiring an additional 44,639 shares in the last quarter. Asset Management One Co. Ltd. raised its holdings in shares of Sabra Health Care REIT by 14.2% in the third quarter. Asset Management One Co. Ltd. now owns 539,004 shares of the real estate investment trust’s stock valued at $10,031,000 after purchasing an additional 66,929 shares during the last quarter. Finally, Citigroup Inc. lifted its position in shares of Sabra Health Care REIT by 104.0% in the third quarter. Citigroup Inc. now owns 316,007 shares of the real estate investment trust’s stock worth $5,881,000 after purchasing an additional 161,071 shares in the last quarter. Institutional investors own 99.40% of the company’s stock.

Wall Street Analysts Forecast Growth

SBRA has been the subject of a number of analyst reports. Mizuho reaffirmed a “neutral” rating and issued a $20.00 target price on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Scotiabank raised their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a report on Friday, October 11th. Truist Financial upped their target price on Sabra Health Care REIT from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Wells Fargo & Company raised shares of Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $16.00 to $20.00 in a research note on Tuesday, October 1st. Finally, Citigroup upgraded Sabra Health Care REIT from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $17.00 to $20.00 in a report on Friday, September 13th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, Sabra Health Care REIT presently has an average rating of “Moderate Buy” and a consensus target price of $19.14.

Sabra Health Care REIT Stock Performance

Shares of SBRA stock opened at $17.50 on Friday. Sabra Health Care REIT, Inc. has a 52 week low of $12.83 and a 52 week high of $20.03. The company has a market capitalization of $4.14 billion, a price-to-earnings ratio of 42.68, a PEG ratio of 2.22 and a beta of 1.24. The company has a 50-day simple moving average of $18.52 and a 200 day simple moving average of $17.09. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.16 and a current ratio of 4.16.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.22). The firm had revenue of $178.00 million for the quarter, compared to the consensus estimate of $177.19 million. Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. During the same quarter in the prior year, the firm earned $0.34 EPS. On average, sell-side analysts predict that Sabra Health Care REIT, Inc. will post 1.39 earnings per share for the current year.

Sabra Health Care REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.86%. The ex-dividend date was Friday, November 15th. Sabra Health Care REIT’s payout ratio is 292.69%.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.